NIZI, MARIA GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 205
EU - Europa 152
AS - Asia 114
AF - Africa 4
Totale 475
Nazione #
US - Stati Uniti d'America 205
IE - Irlanda 46
SG - Singapore 46
IT - Italia 41
HK - Hong Kong 34
VN - Vietnam 20
BE - Belgio 15
SE - Svezia 11
DE - Germania 10
CN - Cina 7
FR - Francia 6
RU - Federazione Russa 6
GB - Regno Unito 5
CI - Costa d'Avorio 4
FI - Finlandia 4
KR - Corea 3
CZ - Repubblica Ceca 2
NL - Olanda 2
PL - Polonia 2
UA - Ucraina 2
IN - India 1
IR - Iran 1
JP - Giappone 1
UZ - Uzbekistan 1
Totale 475
Città #
Chandler 56
Dublin 46
Singapore 42
Hong Kong 30
Boardman 27
Dong Ket 20
West Jordan 18
Brussels 15
Perugia 14
Santa Clara 12
San Mateo 10
Redmond 7
Lawrence 5
Medford 5
Princeton 5
Abidjan 4
Hanover 4
Helsinki 4
New York 4
Altamura 3
Norwalk 3
Seoul 3
Amsterdam 2
Campegine 2
Dallas 2
Fremont 2
Genova 2
Los Angeles 2
Milan 2
Moscow 2
Olomouc 2
Padova 2
Romola 2
San Jose 2
Xian 2
Andover 1
Ardabil 1
Bastia umbra 1
Beijing 1
Cantalice 1
Dearborn 1
Fairfield 1
Hangzhou 1
Kagoya 1
Lodi Vecchio 1
London 1
Navi Mumbai 1
Pasadena 1
Philadelphia 1
Rieti 1
Spoleto 1
Tooting 1
Wilmington 1
Totale 381
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 107
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 73
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 63
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 58
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 53
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 38
Compounds for use in the treatment of cancer and inflammatory conditions 27
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 25
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules 23
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 21
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs 12
Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitors** 2
Totale 502
Categoria #
all - tutte 2.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 1 1 0 0 0 0 0
2020/202141 0 3 1 1 7 1 7 0 0 1 0 20
2021/202271 5 11 4 4 4 1 14 10 5 3 5 5
2022/2023146 5 20 1 23 18 14 0 8 46 5 4 2
2023/2024155 7 22 8 8 9 11 25 0 10 22 8 25
2024/202581 5 22 4 28 22 0 0 0 0 0 0 0
Totale 502